$PPCB

Propanc Biopharma, Inc.

Nasdaq · Healthcare · Pharmaceutical Preparations · Camberwell, Victoria, Australia

PPCB chart

What traders are saying about $PPCB

Latest posts

Propanc Biopharma, Inc. news

Propanc Biopharma, Inc. key financials

USD2026202520242023
Net income-$18.9M-$58.9M-$1.8M-$2.7M
Diluted EPS$-17.62$-371.22$-35324.35$-1.80
Total assets (year end)–$15.1M$78,533$241,907
Cash and equivalents (year end)––––

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

  • S-1S-1
  • 10-K10-K
  • S-1S-1
  • 8-K8-K
  • 10-Q10-Q
  • S-1S-1
  • 8-K8-K
  • 10-Q10-Q
  • S-1S-1
  • 8-K8-K
  • S-1S-1
  • 10-Q10-Q

About Propanc Biopharma, Inc.

Ticker
PPCB (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Camberwell, Victoria, Australia
Incorporated in
DE
Fiscal year end
June 30
SEC CIK
1517681
Former names
Propanc Health Group Corp

Frequently asked questions

What exchange is Propanc Biopharma, Inc. listed on?

Propanc Biopharma, Inc. trades on the Nasdaq under the ticker symbol PPCB.

What industry is Propanc Biopharma, Inc. in?

Propanc Biopharma, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is Propanc Biopharma, Inc. headquartered?

Propanc Biopharma, Inc.'s business address on file with the SEC is in Camberwell, Victoria, Australia.

When does Propanc Biopharma, Inc.'s fiscal year end?

Propanc Biopharma, Inc.'s fiscal year ends on June 30.